Cargando…
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
The ongoing SARS‐CoV‐2 pandemic stresses the need for effective antiviral drugs that can quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By repurposing of broadly active antiviral drugs and compounds that are known to inhibit viral replication of related v...
Autores principales: | Simonis, Alexander, Theobald, Sebastian J, Fätkenheuer, Gerd, Rybniker, Jan, Malin, Jakob J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646058/ https://www.ncbi.nlm.nih.gov/pubmed/33015938 http://dx.doi.org/10.15252/emmm.202013105 |
Ejemplares similares
-
Remdesivir against COVID-19 and Other Viral Diseases
por: Malin, Jakob J., et al.
Publicado: (2020) -
Importance of precise data on SARS-CoV-2 transmission dynamics control
por: Rybniker, Jan, et al.
Publicado: (2020) -
Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV‐2 exposure
por: Theobald, Sebastian J, et al.
Publicado: (2022) -
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021) -
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
por: Pitts, Jared, et al.
Publicado: (2022)